Telix Pharmaceuticals Limited (ASX:TLX)
Australia
· Delayed Price · Currency is AUD 10.20
-0.55 (-5.12%)
At close: Mar 9, 2026
Telix Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -7.13 | 33.69 | 4.21 | -70.74 | -58.54 | Upgrade
|
| Depreciation & Amortization | 20.95 | 5.28 | 4.16 | 3.66 | 3.76 | Upgrade
|
| Other Amortization | 0.46 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.57 | -0.48 | 0.55 | - | - | Upgrade
|
| Stock-Based Compensation | 19.35 | 12.93 | 5.85 | 5.51 | 0.96 | Upgrade
|
| Other Operating Activities | -6.28 | 19.08 | 24.03 | 18.77 | 12.59 | Upgrade
|
| Change in Accounts Receivable | -20.47 | -37.49 | -18.62 | -13.55 | -5.23 | Upgrade
|
| Change in Inventory | -7.64 | -2.13 | -6.55 | -3.41 | -2.05 | Upgrade
|
| Change in Accounts Payable | 28.98 | 28.84 | 18.09 | 20.7 | 5.44 | Upgrade
|
| Change in Unearned Revenue | -9.13 | -6.23 | -3.43 | -1.91 | -1.96 | Upgrade
|
| Change in Other Net Operating Assets | -36.96 | -26.01 | -14 | -2.51 | 1.89 | Upgrade
|
| Operating Cash Flow | -17.29 | 27.49 | 14.27 | -43.48 | -43.14 | Upgrade
|
| Operating Cash Flow Growth | - | 92.60% | - | - | - | Upgrade
|
| Capital Expenditures | -25.69 | -9.12 | -6.31 | -4.78 | -0.97 | Upgrade
|
| Cash Acquisitions | -229.03 | -23.2 | -1 | -0.66 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -18.08 | -13.07 | -0.8 | -4.64 | - | Upgrade
|
| Investment in Securities | -0.89 | -32.91 | -8.7 | - | - | Upgrade
|
| Other Investing Activities | -12.22 | -8.4 | -0.04 | -1.47 | -1.01 | Upgrade
|
| Investing Cash Flow | -285.92 | -86.69 | -16.84 | -11.55 | -1.98 | Upgrade
|
| Long-Term Debt Issued | 0.53 | 427.9 | 4.19 | 2.05 | - | Upgrade
|
| Long-Term Debt Repaid | -6.06 | -2.06 | -1.27 | -0.87 | -0.68 | Upgrade
|
| Net Debt Issued (Repaid) | -5.53 | 425.84 | 2.92 | 1.18 | -0.68 | Upgrade
|
| Issuance of Common Stock | 1.81 | 0.66 | 4.17 | 123.05 | 2.75 | Upgrade
|
| Other Financing Activities | - | -9.71 | - | -5.31 | - | Upgrade
|
| Financing Cash Flow | -3.72 | 416.79 | 7.09 | 118.92 | 2.07 | Upgrade
|
| Foreign Exchange Rate Adjustments | 8.8 | -1.89 | 0.99 | 0.2 | 2.4 | Upgrade
|
| Net Cash Flow | -298.13 | 355.7 | 5.52 | 64.09 | -40.65 | Upgrade
|
| Free Cash Flow | -42.99 | 18.37 | 7.97 | -48.26 | -44.11 | Upgrade
|
| Free Cash Flow Growth | - | 130.64% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -5.35% | 3.56% | 2.39% | -44.35% | -798.67% | Upgrade
|
| Free Cash Flow Per Share | -0.13 | 0.05 | 0.03 | -0.15 | -0.16 | Upgrade
|
| Cash Interest Paid | 13.7 | 3.09 | 0.39 | 0.28 | 0.14 | Upgrade
|
| Cash Income Tax Paid | 21.3 | 2.03 | 6.86 | -11.3 | -8.81 | Upgrade
|
| Levered Free Cash Flow | -36.67 | 53.71 | 41.26 | -20.88 | -27.18 | Upgrade
|
| Unlevered Free Cash Flow | -28.07 | 56.71 | 41.58 | -20.74 | -27.11 | Upgrade
|
| Change in Working Capital | -45.22 | -43.01 | -24.51 | -0.68 | -1.91 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.